Integrins as the pivotal regulators of cisplatin response in tumor cells
Article in Cell Communication and Signaling (May 2024)
The most recent citing publications are shown below. View all 128 publications that cite this research output on Dimensions.
DDR1-targeted therapies: current limitations and future potential
Article in Drug Discovery Today (April 2024)
Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1
Article in Oncogene (April 2024)